Drug recall · April 30, 2025
clomiPRAMINE hydrochloride Capsules USP recall
Why: Failed Impurities/Degradation Specifications: an out of specification result observed in degradation product test (any unspecified degradation product) during 18-month long term stability study.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
clomiPRAMINE hydrochloride Capsules USP, 25 mg, 100-count bottle, Rx only, Manufactured For: Lupin Pharmaceuticals, Inc., Baltimore, MD 21202, United States, Manufactured By: Lupin Limited, Nagpur, 441 108 INDIA, NDC 68180-492-01
- Lots / codes
Lot #: M300442, Exp Date: 6/30/2025
- Quantity
- 2724 bottles
- Company
- Lupin Pharmaceuticals Inc., Naples, FL
- Distribution
- USA nationwide
- Initiated
- April 10, 2025 · Voluntary: Firm initiated
- Classified
- April 18, 2025
- Reported
- April 30, 2025
- Ended
- January 5, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Clomipramine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.